Finance

Lists
Why is BLLN down 5.09%?
Dive Deeper
BLLN:NASDAQ
BillionToOne Inc
$105.15
-5.09%
(-5.64) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLLN...
Open
$111.56
High
$111.93
Low
$104.35
Mkt. cap
5.02B
Avg. vol.
589.14K
Volume
647.78K
P/E ratio
124.14
52-wk high
$150.44
52-wk low
$61.96
EPS
$0.85
Shares outstanding
43.27M
No. of employees
713
Open
$111.56
High
$111.93
Low
$104.35
Mkt. cap
5.02B
Avg. vol.
589.14K
Volume
647.78K
P/E ratio
124.14
52-wk high
$150.44
52-wk low
$61.96
EPS
$0.85
Shares outstanding
43.27M
No. of employees
713
News stories
From web sources and news partners
About BillionToOne Inc
CEO-
Employees713
Founded2016
HeadquartersMenlo Park, California, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to BLLN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BLLN in the last 3 months.
Highest
Current $105.15
$145.00 (+37.90%)
Average
$131.60 (+25.15%)
Lowest
$120.00 (+14.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Reiterated
$130.00
+23.6%
11/10/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
$120.00
+14.1%
11/05/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$145.00
+37.9%
11/05/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
$135.00
+28.4%
11/05/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$128.00
+21.7%
10/01/2026
Matt Larew
William Blair
Buy
Maintained
-
-
08/06/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$90.00
-14.4%
08/06/2026
Mark Massaro
BTIG
Buy
Reiterated
$130.00
+23.6%
08/06/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/07/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$0.48 / $0.30
+58.90%beat
Revenue / Est. (USD)
122.98M / 115.63M
+6.36%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
96.05M
108.39M
109.45M
122.98M
Cost of goods sold
27.45M
29.29M
32.34M
35.84M
Cost of revenue
27.45M
29.29M
32.34M
35.84M
Research and development expenses
14.25M
14.69M
17.32M
20.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.02M
46.57M
54.29M
55.91M
Operating expense
58.27M
61.26M
71.60M
76.12M
Total operating expenses
85.72M
90.55M
103.94M
111.96M
Operating income
10.33M
17.83M
5.50M
11.02M
Other non operating income
-5.82M
301.00K
297.00K
-19.00K
EBT including unusual items
6.30M
18.51M
7.52M
17.39M
EBT excluding unusual items
7.77M
22.77M
10.49M
15.91M
Income tax expense
320.00K
539.00K
-536.00K
1.00K
Effective tax rate
5.08%
2.91%
-7.13%
0.01%
Other operating expenses
-
-
-
-
Net income
2.53M
17.97M
8.05M
17.39M
Net profit margin
2.63%
16.58%
7.36%
14.14%
Earnings per share
0.15
0.54
0.36
0.48
Interest and investment income
3.26M
4.64M
4.69M
4.91M
Interest expense
-3.00K
-10.00K
-8.00K
-6.00K
Net interest expenses
3.26M
4.64M
4.69M
4.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.01M
19.57M
7.33M
13.00M
Gain or loss from assets sale
48.00K
57.00K
7.00K
18.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps